Loading
Latest filing published 18 Aug 2026 for CNS Pharmaceuticals, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Rami Levin is known so far (18 August 2026): an option exercise, in CNS Pharmaceuticals, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration